Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$13,575,473
+$1,906,918 QoQ
Shares Held
53,948
+0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#776
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bell Bank holds $61,862,123 across 10 Drug Manufacturers - General names. ABBV ranks #1 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
53,948 | $13,575,473 | |
| 2 | AMGN |
Amgen Inc
|
33,672 | $12,193,303 | |
| 3 | PFE |
Pfizer Inc
|
484,403 | $11,664,423 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
78,616 | $9,932,345 | |
| 5 | GSK |
GSK plc
|
181,234 | $9,500,285 | |
| 6 | LLY |
ELI LILLY & Co
|
2,255 | $2,704,714 | |
| 7 | JNJ |
Johnson & Johnson
|
5,046 | $1,281,532 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,672 | $471,852 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,575,473 | 53,948 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $11,668,555 | 53,651 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $12,090,547 | 52,915 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $13,949,821 | 60,248 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $13,214,472 | 71,191 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $15,456,289 | 73,770 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $12,998,754 | 73,150 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $13,195,021 | 66,817 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $12,267,453 | 71,522 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $12,958,600 | 71,162 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $10,965,367 | 70,758 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $10,399,618 | 69,768 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $9,446,593 | 70,115 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $11,251,203 | 70,598 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $11,713,007 | 72,477 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $9,829,808 | 73,242 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $10,043,620 | 65,576 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $9,994,405 | 61,652 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $7,633,852 | 56,380 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,260,927 | 48,771 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $5,205,319 | 46,212 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,702,916 | 43,457 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $4,290,821 | 40,045 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,331,836 | 38,039 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,888,811 | 39,609 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,398,982 | 57,737 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||